A few SASP related plasma proteins revealed nonsignificant modest decreases post D ​+ ​Q treatment (e.g., eotaxin, MCP-1, VEGF), which previously have been shown to be elevated in AD [55], and negatively associated with memory in MCI and AD [56]. This evidence concerns the gene CCL2 and Alzheimer disease.